NASDAQ: DTIL PRECISION BIOSCIENCES INC 10-K

Precision Bio posts 50% revenue drop, $46M loss as Novartis deal ends; raises $75M

Filed March 12, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 26, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade DTIL commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.